ClearPoint Neuro, Inc.
CLPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $415,686 | $167,069 | $204,820 | $232,638 |
| - Cash | $20,104 | $23,140 | $27,615 | $54,109 |
| + Debt | $3,568 | $13,941 | $11,986 | $12,284 |
| Enterprise Value | $399,150 | $157,870 | $189,191 | $190,813 |
| Revenue | $31,390 | $23,955 | $20,551 | $16,299 |
| % Growth | 31% | 16.6% | 26.1% | – |
| Gross Profit | $19,122 | $13,614 | $13,531 | $11,123 |
| % Margin | 60.9% | 56.8% | 65.8% | 68.2% |
| EBITDA | -$17,843 | -$20,989 | -$15,577 | -$12,745 |
| % Margin | -56.8% | -87.6% | -75.8% | -78.2% |
| Net Income | -$18,914 | -$22,089 | -$16,435 | -$14,410 |
| % Margin | -60.3% | -92.2% | -80% | -88.4% |
| EPS Diluted | -0.7 | -0.9 | -0.68 | -0.69 |
| % Growth | 22.2% | -32.4% | 1.4% | – |
| Operating Cash Flow | -$8,950 | -$13,720 | -$16,167 | -$12,697 |
| Capital Expenditures | -$275 | -$717 | -$253 | -$168 |
| Free Cash Flow | -$9,225 | -$14,437 | -$16,420 | -$12,865 |